Plus   Neg

Celgene Corp. (CELG) Is Losing Ground Following Downgrade

Morgan Stanley downgraded its rating on shares of Celgene Corp. (CELG) Thursday morning to "Underweight" from "Equal weight."

Celgene gapped open lower Thursday and has continued to decline in early trade. The stock is now down 5.67 at $140.85. Celgene is pulling back from the highs of the year and has set a 3-week low.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Follow RTT